Rucha Patil: Insights from The National Haemophilia Conclave 2026
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”National Haemophilia Conclave 2026
Policy, Protocols, Procedures and the Roadmap Ahead
Delhi | 16–17 May 2026
Delighted to be invited as a speaker at the conclave and present on the topic:
‘Lab Monitoring of Novel Therapies in Haemophilia: Is Thrombin Generation Assay Emerging as a Gold Standard?’ – a very engaging and thought-provoking topic.
It was also an honour to chair a session alongside one of my mentors, Dr. Kanjaksha Ghosh, as co-chair, while another of my mentors delivered the lecture — truly a special moment for me.
Had the opportunity to moderate a very important panel discussion on ‘Haemophilia in Women and Girls: Expanding the Diagnostic Criteria’ with distinguished panelists Dr. KK Radhika, Dr. Smita Kaushik, Dr. Alka Yadav, Dr. Sunita Aggarwal and Dr. Priyanka Agarwal.
A truly enriching and impactful meeting, wonderfully organised by Dr. Naresh Gupta sir and his team.”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’